本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BioNexus Gene Lab Corp.

2.61
-0.1100-4.04%
成交量:1.73萬
成交額:4.60萬
市值:468.91萬
市盈率:-4.92
高:2.70
開:2.68
低:2.60
收:2.72
資料載入中...
2023/10/17

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/16

重要事件披露

Form 8-K - Current report
2023/10/11

重要事件披露

Form 8-K - Current report
2023/09/07

重要事件披露

Form 8-K - Current report
2023/08/16

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/24

重要事件披露

Form 8-K - Current report
2023/07/20

重要事件披露

Form 8-K - Current report
2023/07/17

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/05

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/05/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/09

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2022/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/15

重要事件披露

8-K - Current report
2022/08/15

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/06

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/11/09

[修訂]季度報告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2020/11/03

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]